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ProgesteroneGlutathione peroxidase 3 (GPX3) is an important member of antioxidant enzymes for reducing
reactive oxygen species and maintaining the oxygen balance. Gpx3 mRNA is strongly expressed in
decidual cells from days 5 to 8 of pregnancy. After pregnant mice are treated with GPX inhibitor
for 3 days, pregnancy rate is signiﬁcantly reduced. Progesterone stimulates Gpx3 expression through
PR/HIF1a in mouse endometrial stromal cells. In the decidua, the high level of GPX3 expression is
closely associated with the reduction of hydrogen peroxide (H2O2). Based on our data, GPX3 may
play a major role in reducing H2O2 during decidualization.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Early pregnancy in mammals is vulnerable to stressors [1].
Reactive oxygen species (ROS) is involved in the pathophysiology
of infertility and assisted fertility [2,3]. ROS is deleterious by-
products of aerobic metabolism, including superoxide (O2 /HO2
 ),
hydrogen peroxide (H2O2), and the hydroxyl radical (OH) [4].
In a healthy body, ROS and antioxidants remain in a balance.
Oxidative stress is a disturbance in the pro-oxidant–antioxidant
balance [5]. It is estimated that up to 2% of the oxygen consumed
by mitochondria is partially reduced to form O2 , which is
subsequently converted to H2O2 [6].
In the presence of high H2O2 concentration, catalase is most
effective for metabolizing H2O2. However, the glutathione system
plays a critical role in the presence of low concentrations of either
H2O2 or other peroxides [7]. The key enzyme in the redox cycle
responsible for the reduction of H2O2 is GPX. The mammalian glu-
tathione peroxidase family consists of 8 classes (i.e., Gpx1–Gpx8)
[8]. Glutathione peroxidase 3 (GPX3) belongs to the selenocys-
teine-containing GPX family and is a main antioxidant enzyme inplasma for scavenging ROS derived from normal metabolism or
oxidative insult [9]. GPX3 attenuates oxidant stress by reducing
H2O2 and organic hydroperoxides to their corresponding alcohols
[10].
GPX3 is one of the key enzymes in the cellular defense against
oxidative stress [11]. GPX3 expression is down-regulated both in
rat and human endometrial adenocarcinoma, regardless of tumor
grade or histopathological subtype [11]. GPX3 is one of the up-reg-
ulated genes expressed in receptive phase of human endometrium,
which could represent a useful prognostic tool for selecting IVF pa-
tients [12]. Compared to natural cycles, GPX3 expression shows a
delay in controlled ovarian stimulation (COS) cycles [13]. Based
on our preliminary analysis, Gpx3 is highly expressed in mouse de-
cidua from days 5 to 8 of pregnancy, suggesting that Gpx3may play
a role during decidualization. This study was to examine the
expression, regulation and function of Gpx3 during decidualization.
2. Materials and methods
2.1. Animal treatments
Mature mice (CD1 strain) were maintained in a controlled envi-
ronment (14 h light and 10 h dark cycle). All animal procedures
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tee of South China Agricultural University. Uteri under pseudo-
pregnancy, delayed implantation and activation, steroid
hormonal treatments and deciduoma were collected as described
previously [14]. Day 1 is the day of vaginal plug.
2.2. In situ hybridization
Total RNAs from the mouse uterus on day 8 of pregnancy were
reverse transcribed and ampliﬁed with primers 50-AGA-
AAGGAGATGTGAACG and 50-TAGAATGACTGGGAATGTG (367 bp,
NM_001083929). The ampliﬁed PCR fragment was recovered from
the agarose gel and cloned into pGEM-T plasmid. The cloned frag-
ment of Gpx3 was further veriﬁed by sequencing. The preparation
of digoxigenin-labeled cRNA probes and in situ hybridization of
Gpx3mRNA in mouse uteri was performed as described previously
[15].
2.3. Isolation of mouse endometrial stromal cells and in vitro
decidualization
Mouse endometrial stromal cells were isolated from day 4 preg-
nant uteri as previously described [16]. The cell pellets were resus-Fig. 1. In situ hybridization of Gpx3 mRNA expression in mouse uteri. (A) Day 1 of pre
(D5NI); (D) Implantation site on day 5 of pregnancy (D5I); (E) Day 6 of pregnancy; (F) Day
(PD5); (I) Delayed implantation; (J) Activation of delayed implantation by estrogen; (
decidualization (Deciduoma). Bar = 80 lm.pended in DMEM/F-12 (Sigma) with 2% heat-inactivated FBS
(Gibco). Cells were plated onto 35-mm culture dishes at the con-
centration of 1  106 cells/well. After an initial culture for 1 h,
the medium was changed to remove free ﬂoating cells. In vitro
decidualization of endometrial stromal cells was performed as pre-
viously described [17].
2.4. Isolation of human endometrial stromal cells and in vitro
decidualization
Human endometrial samples were collected from normally cy-
cling women undergoing hysterectomy or endometrial biopsy with
written informed consent. All human procedures were approved
by the Institutional Committee on the Use of Human Subjects in
Medical Research of Bailu Hospital (Xiamen, China). Human endo-
metrial stromal cells were isolated as described previously [18]. In
vitro decidualization of human endometrial stromal cells was per-
formed as previously described [19].
2.5. Transfection of Gpx3 siRNA
Transfections of Gpx3 small interfering RNA (siRNA) were
performed according to Lipofectamine 2000 protocol (Invitrogen).gnancy; (B) Day 4 of pregnancy; (C) Inter-implantation site on day 5 of pregnancy
8 of pregnancy; (G) Day 1 of pseudopregnancy (PD1); (H) Day 5 of pseudopregnancy
K) Uninjected uterine horn for control (Control); (L) Uterine horn under artiﬁcial
Fig. 2. Expression of GPX family in mouse uteri. (A) Gpx3mRNA level; (B) Expression level of GPX3 protein in mouse endometrium at day 5 inter-implantation site (D5NI) and
implantation site (D5I); (C) Gpx1 mRNA level; (D) Gpx2 mRNA level; (E) Gpx4 mRNA level (⁄P < 0.05);
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GenePharma Co., Ltd. (Shanghai, China).
2.6. Real-time RT-PCR
Real-time RT-PCR was performed as previously described [20].
2.7. Western blot
Western blot was performed as previously described [20].
2.8. Detection of hydrogen peroxide concentration
Detection of hydrogen peroxide concentration in endometrial
samples was performed according to the manufacturer’s instruc-
tion of PeroXOquant™ Quantitative Peroxide Assay Kit (Thermo)
with modiﬁcation.
3. Results
3.1. Localization of Gpx3 expression in mouse uterus during early
pregnancy
In situ hybridization was performed to examine the spatial dis-
tribution of Gpx3mRNA in mouse uterus. There was no visible Gpx3
mRNA signal in the uteri from days 1 to 4 (Fig. 1, A and B). On day 5
of pregnancy, Gpx3 mRNA signal was obviously detected in the
subluminal stroma immediately surrounding the implanting blas-
tocyst (Fig. 1D), whereas there was no detectable expression of
Gpx3 at the inter-implantation sites (Fig. 1C). From days 6 to 8,
Gpx3 expression was strongly expressed in the decidua and in-
creased during the process of decidualization (Fig. 1, E and F).3.2. Gpx3 expression during pseudopregnancy, delayed implantation
and artiﬁcial decidualization
To address whether Gpx3 expression was induced by embryo,
we examined the expression of Gpx3 during pseudopregnancy.
From days 1 to 5 of pseudopregnancy, there was no detectable
Gpx3mRNA signal in mouse uteri (Fig. 1, G and H). To further check
whether the expression of Gpx3 was induced by the presence of an
active blastocyst, a delayed implantation model was used. There
was no detectable Gpx3 expression in mouse uterus under delayed
implantation (Fig. 1I). After delayed implantation was activated by
estrogen treatment, Gpx3 expression was highly detected in the
subluminal stromal cells surrounding the implanting embryo
(Fig. 1J).
Because Gpx3 was strongly expressed in the decidua during
early pregnancy, artiﬁcial decidualization was performed to exam-
ine whether Gpx3 was expressed in deciduoma. In the uninjected
uterine horn, Gpx3 mRNA signal was detected in the luminal epi-
thelium and weakly in the glandular epithelium, but not in the
stromal cells (Fig. 1K). In the oil-induced uterine horn for artiﬁcial
decidualization, a strong level of Gpx3 mRNA expression was ob-
served in the decidualized cells (Fig. 1L).
3.3. Quantiﬁcation of Gpx3 and other family members in mouse
endometrium during early pregnancy
We further quantiﬁed the expression levels of Gpx3 mRNA and
its family members by real-time RT-PCR. In order to avoid the
inﬂuence of myometrium, endometrium was isolated from the
whole uterus by squeezing with a needle. Gpx3 expression was sig-
niﬁcantly up-regulated in implantation sites on day 5 of pregnancy
compared with inter-implantation sites, and increased signiﬁ-
cantly on day 8 of pregnancy (Fig. 2A). On day 5, the protein level
Fig. 3. Progesterone regulates the expression level of GPX3 through PR/HIF1a. (A) Gpx3 mRNA expression level after progesterone treatment. Ovariectomized mice were
treated with an injection of progesterone (1 mg/mouse) for 24 h. Progesterone was dissolved in sesame oil and injected subcutaneously. Controls received the vehicle only
(0.1 ml/mouse). (B) Hif1a mRNA expression level after progesterone treatment; (C) Expression level of Gpx3 mRNA 12 h after treatment with progesterone (P4), RU486 or
progesterone plus RU486 (P4 + RU486). Sesame oil (Oil) was injected as a control. For RU486 (Cayman Chemical, Ann Arbor, MI) treatment, mice were injected with RU486
(0.75 mg/mouse) 1 h before progesterone injection. (D) The up-regulation of Gpx3 mRNA induced by progesterone was suppressed by translation inhibitor cycloheximide
(CHX) at 24 h; (E) The up-regulation of HIF1a and GPX3 protein induced by progesterone was suppressed by RU486 at 24 h; (F) The up-regulation of HIF1a and GPX3 protein
induced by progesterone was suppressed by Chrysin, a speciﬁc inhibitor for HIF1a at 24 h; (G) The up-regulation of Gpx3mRNA induced by progesterone was suppressed by
RU486 at 24 h; (H) The up-regulation of Gpx3mRNA induced by progesterone was suppressed by Chrysin at 24 h; (I) GPX3 protein expression induced by 2% O2 (hypoxia) was
inhibited by Chrysin at 24 h. Cells were cultured at 20% O2 (normoxia) as control; (J) GPX3 protein expression induced by deferoxamine mesylate (DFO) was inhibited by
Chrysin at 24 h (⁄P < 0.05).
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1584 X. Xu et al. / FEBS Letters 588 (2014) 1580–1589of GPX3 was also up-regulated at implantation site compared with
inter-implantation site (Fig. 2B).
Levels of Gpx1, Gpx2 and Gpx4 expressions did not show obvious
changes in the endometrium from days 4 to 5 of pregnancy. On day
8 of pregnancy, both Gpx1 and Gpx4 were up-regulated in the
endometrium, whereas Gpx2 was down-regulated (Fig. 2, C–E). Be-
cause the expression of Gpx5, Gpx6 and Gpx7 was very weak in the
mouse uteri from days 1 to 8 of pregnancy, we got no speciﬁc
expression signals by real-time RT-PCR.
3.4. Regulation of Gpx3 expression by progesterone in vivo
Because progesterone is essential for mouse embryo implanta-
tion [21], ovariectomized mice were used to examine whether
Gpx3 expression is regulated by progesterone in vivo. Compared
to control, Gpx3 expression was signiﬁcantly induced from 2 to
12 h after progesterone treatment (Fig. 3A).
Because progesterone can up-regulate Hif1a through progester-
one receptor in vivo [22], we would like to test whether progester-
one regulates Gpx3 through Hif1a. Through in silico analysis, we
identiﬁed a HIF1a binding site in Gpx3 promoter. Both Hif1a and
Gpx3 expressions were signiﬁcantly induced from 2 to 12 h after
progesterone treatment (Fig. 3B), indicating that progesterone
may regulate Gpx3 through Hif1a.
We then checked whether Gpx3 up-regulation by progesterone
was mediated through progesterone receptor. Gpx3 expression was
signiﬁcantly induced by progesterone at 12 h. However, Gpx3 up-
regulation by progesterone was blocked by a pretreatment with
RU486 (1 lM), an antagonist for progesterone receptor, suggestingFig. 4. Gpx3 action under in vitro decidualization. (A) Expression of Gpx3mRNA in mouse
DtprpmRNA in mouse endometrial stromal cells during in vitro decidualization (E2 + P4)
decidualization. EP, E2 + P4; NC, negative control; siGpx3, Gpx3 siRNA. (D) Dtprp expresthat progesterone regulation on Gpx3 is mainly mediated through
progesterone receptor (Fig. 3C).
3.5. Progesterone stimulates GPX3 expression through PR/HIF1a
in vitro
In order to further examine the regulatory mechanism of GPX3
by progesterone, mouse endometrial stromal cells were treated
with progesterone and protein synthesis inhibitor cycloheximide
(CHX, 1 lg/mL). CHX could signiﬁcantly inhibit Gpx3 mRNA induc-
tion by progesterone at 24 h (Fig. 3D), showing that other proteins
may be involved in the regulation of Gpx3. Progesterone should
regulate Gpx3 indirectly.
Stromal cells were then treated with the inhibitor of PR or
HIF1a to further verify whether progesterone regulates Gpx3
through PR and HIF1a. Progesterone-induced up-regulation of
both HIF1a and GPX3 expressions was suppressed by RU486
(1 lM) or a Hif1a inhibitor (Chrysin, 50 lM) at 24 h (Fig. 3, E-H),
indicating that progesterone stimulated GPX3 expression through
PR/HIF1a in mouse endometrial stromal cells.
3.6. Effects of hypoxia on GPX3 expression
Since it is reported that hypoxia can induce HIF1a accumulation
in all cell types by inhibiting its ubiquitylated degradation pathway
[23], stromal cells were treated with either 2% O2 or deferoxamine
mesylate (DFO, 150 lM) for 24 h to determine whether GPX3
expression was stimulated under the hypoxia environment. Both
GPX3 and HIF1a were signiﬁcantly up-regulated by either 2% O2endometrial stromal cells during in vitro decidualization (E2 + P4). (B) Expression of
. (C) Gpx3 expression was signiﬁcantly down-regulated by Gpx3 siRNA under in vitro
sion was signiﬁcantly inhibited by Gpx3 siRNA.
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expression was abrogated by a Hif1a inhibitor (Chrysin, 50 lM)
(Fig. 3, I and J), indicating that HIF1a is involved in hypoxia-in-
duced GPX3 expression.
3.7. Gpx3 expression during in vitro decidualization
Decidual/trophoblast prolactin-related protein (Dtprp) is a reli-
able marker for decidualization in mice [24,25]. We examined
whether Dtprp and Gpx3 was expressed under in vitro decidualiza-
tion. After mouse stromal cells were induced for in vitro decidual-
ization with both estrogen and progesterone, Gpx3 expression
signiﬁcantly increased from 24 to 96 h of culture (Fig. 4A). Dtprp
expression was also signiﬁcantly induced from 24 to 96 h of cul-
ture (Fig. 4B). After GPX3 expression was signiﬁcantly down-regu-
lated by Gpx3 siRNA under in vitro decidualization (Fig. 4C), Dtprp
expression was inhibited (Fig. 4D).
3.8. Post-transcriptional regulation of GPX3 expression by sodium
selenite
Uterine stromal cells were treated with different concentrations
of sodium selenite to examine its effects on GPX3 protein expres-
sion at 24 h. As the concentration of sodium selenite increased,
GPX3 protein expression enhanced gradually. But when the con-
centration of sodium selenite was higher than 0.1 lM, GPX3 pro-
tein expression decreased slightly (Fig. 5A). It is possible that a
high level of selenium may produce toxic effects since selenium
belongs to trace elements. Therefore, culture medium was supple-
mented with 0.1 lM sodium selenite in rest of the treatments
required.
No matter whether sodium selenite was in the medium, both
estrogen and progesterone could induce Gpx3 mRNA expressionFig. 5. The post-transcriptional regulation of GPX3 by sodium selenite (Na2SeO3) in
stromal cells under in vitro decidualization. (A) Effects of different concentrations of
sodium selenite (Na2SeO3) on the expression level of GPX3 protein at 24 h; (B)
Effects of Na2SeO3 on the expression level of Gpx3 mRNA under in vitro decidu-
alization at 24 h; (C) Effects of Na2SeO3 on the expression level of GPX3 protein
under in vitro decidualization at 24 h (⁄P < 0.05).at 24 h (Fig. 5B). However, GPX3 protein expression was not de-
tected when culture medium didn’t contain sodium selenite in
the control. Only in the groups containing sodium selenite, both
estrogen and progesterone could induce GPX3 protein expression
(Fig. 5C), showing that selenium stimulates GPX3 protein expres-
sion through post-transcriptional regulation.
3.9. Concentration of hydrogen peroxide in mouse endometrium
The concentration of hydrogen peroxide at implantation sites
was signiﬁcantly lower than that of the inter-implantation sites
on day 5 of pregnancy (Fig. 6A). On the contrary, GPX3 was signif-
icantly increased in implantation sites on day 5 of pregnancy com-
pared with inter-implantation sites, indicating that GPX3 may play
a role in reducing H2O2 in mouse endometrium.
3.10. GPX3 reduces H2O2 during in vitro decidualization
During in vitro decidualization, the concentration of H2O2 in the
supernatant of mouse stromal cells was signiﬁcantly down-regu-
lated, which was blocked by mercaptosuccinic acid, an enzyme
activity inhibitor of all GPXs at 96 h (Fig. 6B). Although the reduc-
tion of H2O2 by GPX3 was inhibited by mercaptosuccinic acid, mer-
captosuccinic acid was unable to inhibit GPX3 protein expression
induced by both estrogen and progesterone at 96 h (Fig. 6C). The
result of real-time RT-PCR showed that Gpx3mRNA in decidualized
cells was signiﬁcantly up-regulated (Fig. 6D), Gpx1 mRNA was sig-
niﬁcantly down-regulated (Fig. 6E), and Gpx4mRNA was invariable
in decidualized cells compared with control at 96 h (Fig. 6F). These
data indicated that GPX3 also played a major role for reducing
H2O2 in decidualized cells in vitro.
Gpx3 siRNA could effectively inhibit the expression of GPX3
protein at 48 h (Fig. 6G). Gpx3 siRNA treatment could block the
down-regulation of H2O2 concentration in the supernatant of
mouse stromal cells undergoing in vitro decidualization at 48 h
(Fig. 6H). These data further conﬁrmed that GPX3 could reduce
H2O2 in decidualized cells in vitro.
3.11. GPX3 reduces H2O2 in human stromal cells undergoing in vitro
decidualization
Human endometrium stromal cells were used to investigate
whether human GPX3 had similar function as mouse Gpx3. The
concentration of H2O2 in the supernatant of human stromal cells
undergoing in vitro decidualization was signiﬁcantly down-regu-
lated, which was blocked by GPX inhibitor on day 6 (Fig. 7A), indi-
cating that GPX3 had a similar function in human endometrium
cells. Mercaptosuccinic acid could inhibit GPX3 enzyme activity,
but also could not inhibit GPX3 protein under in vitro decidualiza-
tion on day 6 (Fig. 7B). GPX3 mRNA expression was signiﬁcantly
enhanced after in vitro decidualization was induced for 6 days
(Fig. 7C). PRL and IGFBP-1were molecular markers of human decid-
ualization [26,27]. Both IGFBP1 and PRL were signiﬁcantly up-reg-
ulated after stromal cells were induced for in vitro decidualization
for 6 days (Fig. 7, D and E).
3.12. Pregnancy rate drops after intraperitoneal injection of
mercaptosuccinic acid
In order to investigate the role of GPX during pregnancy, preg-
nant mice were treated with GPX inhibitor. After intraperitoneal
injection of GPX inhibitor for 3 days from day 5 of pregnancy, preg-
nancy rate was signiﬁcantly reduced on day 8 of pregnancy (Fig. 8),
indicating that GPX may play an important role in the process of
implantation and decidualization.
Fig. 6. Effects of GPX3 on hydrogen peroxide (H2O2) in mouse decidualized cells. (A) The concentration of H2O2 on days 4 (D4), 5 (D5NI and D5I) and 8 (D8) in mouse
endometrium. D5NI: inter-implantation site on day 5; D5I: implantation site on day 5; (B) Effects of GPX inhibitor (mercaptosuccinic acid, MS) on H2O2 concentration at 96 h;
(C) Mercaptosuccinic acid has no effect on GPX3 protein expression at 96 h; (D) Gpx3mRNA expression is signiﬁcantly up-regulated under in vitro decidualization at 96 h; (E)
Gpx1mRNA level is signiﬁcantly down-regulated under in vitro decidualization at 96 h; (F) Gpx4mRNA expression was not changed under in vitro decidualization at 96 h; (G)
Effects of Gpx3 siRNA on the expression of GPX3 protein at 48 h; (H) Effects of Gpx3 siRNA on H2O2 concentration in the supernatant at 48 h (⁄P < 0.05).
1586 X. Xu et al. / FEBS Letters 588 (2014) 1580–1589
Fig. 7. The concentration of hydrogen peroxide (H2O2) in human endometrial stroma cells under in vitro decidualization. (A) Effects of GPX inhibitor (mercaptosuccinic acid,
MS) on H2O2 concentration on day 6; (B) Mercaptosuccinic acid has no effect on GPX3 protein expression on day 6; In stromal cells under in vitro decidualization, the levels of
GPX3 (C), PRL (D) and IGFBP1 (E) mRNA expression are signiﬁcantly up-regulated on day 6 (⁄P < 0.05).
Fig. 8. Effects of mercaptosuccinic acid (MS) on mouse pregnancy. Mercaptosucci-
nic acid, a speciﬁc inhibitor for GPX, was dissolved in saline and injected i.p.
(3.5 mg/mouse/day, Sigma) on days 5 (0900 h), 6 (0900 h) and 7 (0900 h) of
pregnancy for three times. Controls received saline (0.1 ml/mouse). Mice were
sacriﬁced in the morning of day 8, and ovulation was conﬁrmed by counting the
number of corpus luteum. Then uteri were photographed and collected.
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4.1. Speciﬁc expression of Gpx3 during decidualization
In this study, we ﬁrst showed that Gpx3 is strongly expressed in
the decidua from days 5 to 8 of pregnancy. Gpx3 expression is not
detected during pseudopregnancy and under delayed implanta-
tion, but is detected after embryo activation and under artiﬁcial
decidualization. Compared to delayed implantation, Gpx3 is up-
regulated by 12.28-fold after delayed implantation is activated
by estrogen [28]. GPX3 is highly expressed in secretory phase endo-metrium but only detectable at very low levels in the proliferative
phase. Similarly, real-time RT-PCR studies showed an average 50-
fold increase in GPX3 expression in secretory phase versus prolifer-
ative phase endometrium [29]. GPX3 is one of the up-regulated
window of implantation genes delayed in controlled ovarian stim-
ulation cycles compared with natural cycles [13].
4.2. Progesterone regulates Gpx3 expression through PR/HIF1a
In this study, Gpx3 expression is signiﬁcantly induced by pro-
gesterone both in vivo and in vitro. Furthermore, the up-regulation
of Gpx3 by progesterone is signiﬁcantly blocked by RU486, suggest-
ing that progesterone regulation on Gpx3 is mainly mediated
through progesterone receptor. However, Gpx3 expression in
mouse skeletal muscles is induced both acutely and chronically
by estradiol-17b [30].
Blastocyst implantation occurs in a uterine environment low in
oxygen (18 mmHg or 2%), a condition that appreciably changes
(60 mmHg or 8%) [31–33]. Both the luminal epithelium and stro-
ma exhibit Hif1a mRNA expression on day 5 of pregnancy. On day
8, Hif1amRNA expression shows a further increase in the decidual
bed [22]. The levels of Hif1a mRNA shows a gradual increase from
2 h after an injection of P4 and reaches a peak at 24 h [22]. In cul-
tured mouse endometrial stromal cells, the up-regulation of HIF1a
and GPX3 protein induced by progesterone is suppressed by
RU486, indicating that progesterone stimulates HIF1a and GPX3
expression through PR. Progesterone cannot induce Hif1a expres-
sion in PR knockout mice, showing that progesterone induces Hif1a
1588 X. Xu et al. / FEBS Letters 588 (2014) 1580–1589though PR [22]. In our study, hypoxia induced by 2% O2 or DFO also
stimulates GPX3 expression. The up-regulation of GPX3 induced by
progesterone is suppressed by a Hif1a inhibitor, Chrysin. Addition-
ally, Hif1a expression in decidua is overlapped with Gpx3 expres-
sion, suggesting that progesterone stimulates GPX3 expression
through HIF1a. In silico analysis of Gpx3 promoter also identiﬁes
a HIF1a binding site. Hypoxia is identiﬁed as a strong transcrip-
tional regulator of GPX3 expression, in part through the presence
of HIF1a binding site [34].
4.3. Gpx3 is involved in decidualization through reducing H2O2
We showed that the concentration of H2O2 at implantation sites
is signiﬁcantly lower than that of inter-implantation sites on day 5
of pregnancy. The expression of Gpx3 is signiﬁcantly increased at
implantation sites and other members of GPX family are not signif-
icantly up-regulated in implantation sites, suggesting that GPX3
may play a major role in reducing H2O2 in mouse endometrium.
The concentration of H2O2 in the supernatant of stromal cells
undergoing in vitro decidualization is signiﬁcantly down-regu-
lated, which can be blocked by GPX inhibitor or Gpx3 siRNA. There
were similar results from human endometrial stromal cells under-
going in vitro decidualization, indicating that GPX3 has a similar
function in human endometrium. It is shown that the endome-
trium is better equipped to detoxify ROS upon decidualization
in vivo [35]. Gpx3 may play a role in detoxifying ROS since it is
strongly expressed in decidua and deciduoma.
Oxidative stress has an important role in the normal function-
ing of the female reproductive system and in the pathogenesis of
female infertility [36,37]. The enzymic activity of placental GPX
is also signiﬁcantly reduced in tissues from preeclamptic women
compared to normotensive women [38]. Gpx3 is identiﬁed as a
potential biomarker for rat endometrial adenocarcinoma as
Gpx3 expression is greatly down-regulated in rat endometrial
adenocarcinoma [39].
Although Gpx3 is strongly expressed in mouse decidua,
Gpx3(/) mice show no overt reproductive phenotypes compared
with WT mice [40]. It is still unknown whether other members of
GPX family are up-regulated or compensated in Gpx3(/) mouse
uterus. Interestingly, homozygous Dtprp-null female mice are
viable and fertile, and produce normal litter sizes. However,
pregnancy failure is observed when pregnant Dtprp-null mice are
exposed to hypoxia [41]. Therefore, it is better to check whether
Gpx3(/) mice can reproduce normally under hypoxia or other
stress conditions.
In conclusion, GPX3 is strongly expressed in mouse decidua.
Both progesterone and hypoxia can stimulate GPX3 expression.
GPX3 may be essential for mouse decidualization through reducing
H2O2.
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